DEC 23, 2016 1:42 PM PST

Men Sue J&J Over Breast Growth Side Effect

WRITTEN BY: Xuan Pham

A Johnson & Johnson drug approved for the treatment of a handful of mood or mental disorders is coming under fire for causing unwanted male breast development.

Image credit: Pixabay.com

Risperdal was approved in the US market in the early 1990s. It is prescribed mainly as an antipsychotic, for the treatment of bipolar disorder and schizophrenia. It is also prescribed as a mood stabilizer for irritability in people with autism.

However, among the drug’s side effects, patients say there another one that they were not told about: gynecomastia, or development of male breasts. Specifically a group of men who took the drug in the early 2000’s say that gynecomastia was not disclosed to them clearly.

In total, the new lawsuit will represent 13,000 patients who Jason Itkin, the lead lawyer, say were “injured by the drug.”

Among the patients is Eddie Bible. Bible recounts having taken Risperdal for the treatment of anxiety and bipolar disorder when he was 13. "They put me on this Risperdal. The doctors said, 'Well, Risperdal was helping some.' To me, it didn't really help, because a year and a half later, I had gynecomastia."

Bible’s side effects were so bad that he thought at one point he would have to get a training bra. He also vividly recalls being publicly shamed for his appearance. "I'd go to the locker room, and people would point and stare. Everybody picking on you for being a boy with boobs. ... It's just ... depressing,” said Bible.

It wasn’t until 2006 that the manufacturers disclosed gynecomastia as a side effect of Risperdal. And that was too little too late for Bible and the thousands of others who had already taken the drug without full knowledge of how the drug would affect their bodies. "If I knew what the side effects would be of the medication, I would have never taken it," Bible said

"Looking back on it, I feel like an experiment," he said.

This is not the first time Risperdal has been in the legal spotlight. In 2012, Johnson & Johnson settled a multimillion dollar lawsuit for promoting the drug can treat dementia without sufficient evidence or approval.

For Bible and others like him, suing Johnson & Johnson for disfigurement goes beyond monetary compensation. They want to make sure that a drug company that helps treat conditions in kids live up to the highest standards so as to avoid future damages, the likes of which they’ve had to endure.

However, the road to getting compensation may be harder than expected. Earlier this week, a Pennsylvania judge ruled to dismiss the case on the grounds of "inadequate" expert testimony. The decision is currently being appealed.

Additional sources: CNN

About the Author
I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 23, 2022
Clinical & Molecular DX
Accelerate diagnostic development with the right supplier
JUN 23, 2022
Accelerate diagnostic development with the right supplier
Diagnostic assays like the one you’re developing are in demand. But your task isn’t simple. Set yourself up ...
JUL 08, 2022
Microbiology
Good Bacteria in the Urinary Tract Can Eliminate Pathogens
JUL 08, 2022
Good Bacteria in the Urinary Tract Can Eliminate Pathogens
Bacteria are everywhere, even in our bodies. While some might be dangerous, many have beneficial, positive roles. Resear ...
JUL 13, 2022
Clinical & Molecular DX
Nipah Virus: Moderna Invests in a Vaccine for the Virus that Fauci Calls a 'Pandemic Threat'
JUL 13, 2022
Nipah Virus: Moderna Invests in a Vaccine for the Virus that Fauci Calls a 'Pandemic Threat'
In Malaysia in the fall of 1998, a mystery ailment swept through the local pig-farming community, eventually leading to ...
JUL 28, 2022
Clinical & Molecular DX
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
JUL 28, 2022
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
Pancreatic cancer typically does not cause symptoms until after it has spread to other organs. This makes it very diffic ...
AUG 08, 2022
Cancer
A Protein Detectable in Blood Linked to Diabetes Onset and Cancer Mortality
AUG 08, 2022
A Protein Detectable in Blood Linked to Diabetes Onset and Cancer Mortality
Type 2 diabetes (T2D) is a well-established risk factor associated with some types of cancer, including liver, pancreas, ...
AUG 10, 2022
Technology
Microrobotics for Endodontic Root Canal Treatment and Diagnosis
AUG 10, 2022
Microrobotics for Endodontic Root Canal Treatment and Diagnosis
Root canal, anyone? With a reputation for being one of the most dreaded dental procedures, root canal treatment involves ...
Loading Comments...